Suppression of polyglutamine-induced toxicity in cell and animal models of Huntington's disease by ubiquilin

Human Molecular Genetics

Volumn 15, Issue 6, 2006, Pages 1025-1041

  Wang, Hongmin ^a   Lim, Precious J ^a   Yin, Chaobo ^a   Rieckher, Matthias ^a   Vogel, Bruce E ^a   Monteiro, Mervyn J ^a  

^a UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; DNA; GREEN FLUORESCENT PROTEIN; HUNTINGTIN; HYBRID PROTEIN; NERVE PROTEIN; POLYGLUTAMINE; UBIQUILIN 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BODY MOVEMENT; BRAIN CELL; CAENORHABDITIS ELEGANS; CELL DEATH; CYTOTOXICITY; DISEASE MODEL; ENZYME ACTIVATION; GENE CONSTRUCT; GENE OVEREXPRESSION; HELA CELL; HUNTINGTON CHOREA; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN AGGREGATION; REGULATORY MECHANISM; RNA INTERFERENCE; WILD TYPE;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BEHAVIOR, ANIMAL; CAENORHABDITIS ELEGANS; CARRIER PROTEINS; CELL CYCLE PROTEINS; CELL LINE; CELLS, CULTURED; DISEASE MODELS, ANIMAL; HELA CELLS; HUMANS; HUNTINGTON DISEASE; MICE; NERVE TISSUE PROTEINS; NEURONS; NUCLEAR PROTEINS; PEPTIDES; RECOMBINANT FUSION PROTEINS; RNA INTERFERENCE;

ANIMALIA; CAENORHABDITIS ELEGANS;

EID: 33644771265     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddl017     Document Type: Article

References (48)

1. Bates, G., Harper, P. and Jones, L. (2002) Huntington's Disease, 3rd edn. Oxford University Press, Oxford.
2. The Huntington's Disease Collaborative Research Group. (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell, 72, 971-983.
3. Landles, C. and Bates, G.P. (2004) Huntingtin and the molecular pathogenesis of Huntington's disease. Fourth in molecular medicine review series. EMBO Rep., 5, 958-963.
4. Michalik, A. and Van Broeckhoven, C. (2003) Pathogenesis of polyglutamine disorders: Aggregation revisited. Hum. Mol. Genet., 12 (Spec No. 2), R173-R186.
5. La Spada, A.R. and Taylor, J.P. (2003) Polyglutamines placed into context. Neuron, 38, 681-684.
6. Ross, C.A. (2002) Polyglutamine pathogenesis: Emergence of unifying mechanisms for Huntington's disease and related disorders. Neuron, 35, 819-822.
7. Ross, C.A. and Poirier, M.A. (2004) Protein aggregation and neurodegenerative disease. Nat. Med., 10 (suppl.), S10-S17.
8. Arrasate, M., Mitra, S., Schweitzer, E.S., Segal, M.R. and Finkbeiner, S. (2004) Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature, 431, 805-810.
9. Bowman, A.B., Yoo, S.Y., Dantuma, N.P. and Zoghbi, H.Y. (2005) Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation. Hum. Mol. Genet., 14, 679-691.
10. Wexler, N.S., Lorimer, J., Porter, J., Gomez, F., Moskowitz, C., Shackell, E., Marder, K., Penchaszadeh, G., Roberts, S.A., Gayan, J. et al. (2004) Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. Proc. Natl Acad. Sci. USA, 101, 3498-3503.
11. Mah, A.L., Perry, G., Smith, M.A. and Monteiro, M.J. (2000) Identification of ubiquilin, a novel presenilin interactor that increases presenilin protein accumulation. J. Cell Biol., 151, 847-862.
12. Davidson, J.D., Riley, B., Burright, E.N., Duvick, L.A., Zoghbi, H.Y. and Orr, H.T. (2000) Identification and characterization of an ataxin-1-interacting protein: A1Up, a ubiquitin-like nuclear protein. Hum. Mol. Genet., 9, 2305-2312.
13. Doi, H., Mitsui, K., Kurosawa, M., Machida, Y., Kuroiwa, Y. and Nukina, N. (2004) Identification of ubiquitin-interacting proteins in purified polyglutamine aggregates. FEBS Lett., 571, 171-176.
14. Narain, Y., Wyttenbach, A., Rankin, J., Furlong, R.A. and Rubinsztein, D.C. (1999) A molecular investigation of true dominance in Huntington's disease. J. Med. Genet., 36, 739-746.
15. Wyttenbach, A., Sauvageot, O., Carmichael, J., Diaz-Latoud, C., Arrigo, A.P. and Rubinsztein, D.C. (2002) Heat shock protein 27 prevents cellular polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtin. Hum. Mol. Genet., 11, 1137-1151.
16. Atabay, C., Cagnoli, C.M., Kharlamov, E., Ikonomovic, M.D. and Manev, H. (1996) Removal of serum from primary cultures of cerebellar granule neurons induces oxidative stress and DNA fragmentation: Protection with antioxidants and glutamate receptor antagonists. J. Neurosci. Res., 43, 465-475.
17. Iacovitti, L., Stull, N.D. and Johnston, K. (1997) Melatonin rescues dopamine neurons from cell death in tissue culture models of oxidative stress. Brain Res., 768, 317-326.
18. Andoh, T., Chock, P.B. and Chiueh, C.C. (2002) The roles of thioredoxin in protection against oxidative stress-induced apoptosis in SH-SY5Y cells. J. Biol. Chem., 277, 9655-9660.
19. Pandey, S., Lopez, C. and Jammu, A. (2003) Oxidative stress and activation of proteasome protease during serum deprivation-induced apoptosis in rat hepatoma cells; inhibition of cell death by melatonin. Apoptosis, 8, 497-508.
20. Piret, J.P., Lecocq, C., Toffoli, S., Ninane, N., Raes, M. and Michiels, C. (2004) Hypoxia and CoCl2 protect HepG2 cells against serum deprivation- and t-BHP-induced apoptosis: A possible anti-apoptotic role for HIF-1. Exp. Cell Res., 295, 340-349.
21. Giuliano, P., De Cristofaro, T., Affaitati, A., Pizzulo, G.M., Feliciello, A., Criscuolo, C., De Michele, G., Filla, A., Avvedimento, E.V. and Varrone, S. (2003) DNA damage induced by polyglutamine-expanded proteins. Hum. Mol. Genet., 12, 2301-2309.
22. Wanker, E.E., Scherzinger, E., Heiser, V., Sittler, A., Eickhoff, H. and Lehrach, H. (1999) Membrane filter assay for detection of amyloid-like polyglutamine-containing protein aggregates. Methods Enzymol., 309, 375-386.
23. Massey, L.K., Mah, A.L. and Monteiro, M.J. (2005) Ubiquilin regulates presenilin endoproteolysis and modulates gamma-secretase components, Pen-2 and Nicastrin. Biochem. J., 391, 513-525.
24. Satyal, S.H., Schmidt, E., Kitagawa, K., Sondheimer, N., Lindquist, S., Kramer, J.M. and Morimoto, R.I. (2000) Polyglutamine aggregates alter protein folding homeostasis in Caenorhabditis elegans. Proc. Natl Acad. Sci. USA, 97, 5750-5755.
25. Morley, J.F., Brignull, H.R., Weyers, J.J. and Morimoto, R.I. (2002) The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans. Proc. Natl Acad. Sci. USA, 99, 10417-10422.
26. Caldwell, G.A., Cao, S., Sexton, E.G., Gelwix, C.C., Bevel, J.P. and Caldwell, K.A. (2003) Suppression of polyglutamine-induced protein aggregation in Caenorhabditis elegans by torsin proteins. Hum. Mol. Genet., 12, 307-319.
27. Yamanaka, K., Okubo, Y., Suzaki, T. and Ogura, T. (2004) Analysis of the two p97/VCP/Cdc48p proteins of Caenorhabditis elegans and their suppression of polyglutamine-induced protein aggregation. J. Struct. Biol., 146, 242-250.
28. Okkema, P.G., Harrison, S.W., Plunger, V., Aryana, A. and Fire, A. (1993) Sequence requirements for myosin gene expression and regulation in Caenorhabditis elegans. Genetics, 135, 385-404.
29. Timmons, L. and Fire, A. (1998) Specific interference by ingested dsRNA. Nature, 395, 854.
30. Timmons, L., Court, D.L. and Fire, A. (2001) Ingestion of bacterially expressed dsRNAs can produce specific and potent genetic interference in Caenorhabditis elegans. Gene, 263, 103-112.
31. Bertram, L., Hiltunen, M., Parkinson, M., Ingelsson, M., Lange, C., Ramasamy, K., Mullin, K., Menon, R., Sampson, A.J., Hsiao, M.Y. et al. (2005) Family-based association between Alzheimer's disease and variants in UBQLN1. N. Engl. J. Med., 352, 884-894.
32. Hay, D.G., Sathasivam, K., Tobaben, S., Stahl, B., Marber, M., Mestril, R., Mahal, A., Smith, D.L., Woodman, B. and Bates, G.P. (2004) Progressive decrease in chaperone protein levels in a mouse model of Huntington's disease and induction of stress proteins as a therapeutic approach. Hum. Mol. Genet., 13, 1389-1405.
33. Gokhale, K.C., Newnam, G.P., Sherman, M.Y. and Chernoff, Y.O. (2005) Modulation of prion-dependent polyglutamine aggregation and toxicity by chaperone proteins in the yeast model. J. Biol. Chem., 280, 22809-22818.
34. Thomas, M., Yu, Z., Dadgar, N., Varambally, S., Yu, J., Chinnaiyan, A.M. and Lieberman, A.P. (2005) The unfolded protein response modulates toxicity of the expanded glutamine androgen receptor. J. Biol. Chem., 280, 21264-21271.
35. Sakahira, H., Breuer, P., Hayer-Hartl, M.K. and Hartl, F.U. (2002) Molecular chaperones as modulators of polyglutamine protein aggregation and toxicity. Proc. Natl Acad. Sci. USA, 99(Suppl. 4), 16412-16418.
36. Kleijnen, M.F., Alarcon, R.M. and Howley, P.M. (2003) The ubiquitin-associated domain of hPLIC-2 interacts with the proteasome. Mol. Biol. Cell, 14, 3868-3875.
37. Massey, L.K., Mah, A.L., Ford, D.L., Miller, J., Liang, J., Doong, H. and Monteiro, M.J. (2004) Overexpression of ubiquilin decreases ubiquitination and degradation of presenilin proteins. J. Alzheimers Dis., 6, 79-92.
38. Chen, L. and Madura, K. (2002) Rad23 promotes the targeting of proteolytic substrates to the proteasome. Mol. Cell. Biol., 22, 4902-4913.
39. Elsasser, S., Chandler-Militello, D., Muller, B., Hanna, J. and Finley, D. (2004) Rad23 and Rpn10 serve as alternative ubiquitin receptors for the proteasome. J. Biol. Chem., 279, 26817-26822.
40. Verma, R., Oania, R., Graumann, J. and Deshaies, R.J. (2004) Multiubiquitin chain receptors define a layer of substrate selectivity in the ubiquitin-proteasome system. Cell, 118, 99-110.
41. Kaye, F.J., Modi, S., Ivanovska, I., Koonin, E.V., Thress, K., Kubo, A., Kornbluth, S. and Rose, M.D. (2000) A family of ubiquitin-like proteins binds the ATPase domain of Hsp70-like Stch. FEBS Lett., 467, 348-355.
42. Ko, H.S., Uehara, T. and Nomura, Y. (2002) Role of ubiquilin associated with protein-disulfide isomerase in the endoplasmic reticulum in stress-induced apoptotic cell death. J. Biol. Chem., 277, 35386-35392.
43. Slifer, M.A., Martin, E.R., Haines, J.L. and Pericak-Vance, M.A. (2005) The ubiquilin 1 gene and Alzheimer's disease. N. Engl. J. Med., 352, 2752-2753; author reply 2752-2753.
44. Kamboh, M.I., Minster, R.L., Feingold, E. and Dekosky, S.T. (2005) Genetic association of ubiquilin with Alzheimer's disease and related quantitative measures. Mol. Psychiatry, November 22, 2005 advanced online [Epub ahead of print], doi: 10.1038/sj.4001775.
45. Brouwers, N., Sleegers, K., Engelborghs, S., Bogaerts, V., van Duijn, C.M., Paul De Deyn, P., Van Broeckhoven, C. and Dermaut, B. (2006) The UBQLN1 polymorphism, UBQ-8i, at 9q22 is not associated with Alzheimer's disease with onset before 70 years. Neurosci. Lett., 392, 72-74.
46. Smemo, S., Nowotny, P., Hinrichs, A.L., Kauwe, J.S., Cherny, S., Erickson, K., Myers, A.J., Kaleem, M., Marlowe, L., Gibson, A.M. et al. (2005) Ubiquilin 1 polymorphisms are not associated with late-onset Alzheimer's disease. Ann. Neurol., 59, 21-26.
47. Brenner, S. (1974) The genetics of Caenorhabditis elegans. Genetics, 77, 71-94.
48. Mello, C. and Fire, A. (1995) DNA transformation. Methods Cell Biol., 48, 451-482.